Symbols

APGE

Apogee Therapeutics·NASDAQ

--(--)

7.46 / 10

Outperform

Money flow analysis registers 7.82/10, showing robust fund flow characteristics. Positive momentum in Small and Medium is countered by negative tendencies in overall, block, Large, and Extra-large, suggesting positive flow conditions. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(71.4%), Buy(14.3%), Neutral(14.3%) from 7 analytical reports, supported by 7.09 historical weighted rating.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

71%

Buy

14%

Hold

Sell

Strong Sell

Date2026-03-18

InstitutionTruist Securities

Times predicted1

Historical Win Rate0.0%

What is the market sentiment for APGE?

APGE holds a Bullish analyst rating, with 71% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.46/10 (Outperform).